SUPERNUS PHARMACEUTICALS, INC.·4

Jan 23, 4:33 PM ET

Hudson Frederick M. 4

4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Jan 23, 2025

Insider Transaction Report

Form 4
Period: 2025-01-22
Transactions
  • Exercise/Conversion

    Director Stock Option (Right to Buy)

    2025-01-2220,0000 total
    Exercise: $9.13From: 2016-03-03Exp: 2025-03-03Common Stock (20,000 underlying)
  • Exercise/Conversion

    Common Stock

    2025-01-22$9.13/sh+20,000$182,60048,395 total

Documents

1 file
  • 4
    wk-form4_1737668026.xmlPrimary

    FORM 4